Keyphrases
Potential Biomarkers
100%
Hyperuricemia
100%
Steatosis
100%
Non-alcoholic Fatty Liver Disease (NAFLD)
61%
Metabolomics Data
15%
Time-of-flight Mass Spectrometry
7%
Disease Progression
7%
Metabolism
7%
Liquid Chromatography
7%
Metabolic Alterations
7%
Metabolic Profiling
7%
Receptor Activation
7%
Inosine
7%
Disease Prevention
7%
Metabolic Disorders
7%
Cholesterol Ester
7%
Nucleotide Degradation
7%
Health Screening
7%
Liver X Receptor
7%
Retinoid X Receptor
7%
Phospholipase
7%
Molecular Detection
7%
Phosphatidic Acid
7%
Purine nucleotides
7%
Clinical Scenarios
7%
Early Detection
7%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Hyperuricemia
100%
Steatosis
100%
Nonalcoholic Fatty Liver
61%
Normal Human
7%
Disease Exacerbation
7%
Inosine
7%
Cholesterol Ester
7%
Phosphatidic Acid
7%
Purine Nucleotide
7%
Phospholipase
7%
Retinoid X Receptor
7%
Liver X Receptor
7%
Immunology and Microbiology
Non-Alcoholic Fatty Liver Disease
100%
Time-of-Flight Mass Spectrometry
12%
Normal Human
12%
Purine Metabolism
12%
Liquid Chromatography
12%
Mass Screening
12%